Related Experiment Videos
Bone remodeling alterations in myelodysplastic syndrome
L Mellibovsky1, A Diez, S Serrano
1Department of Internal Medicine, Hospital Universitari del Mar, Barcelona, Spain.
Bone
|October 1, 1996
Summary
Myelodysplastic syndromes (MDS) significantly impact bone remodeling, leading to adynamic bone characterized by reduced bone formation and osteoclast activity. These findings highlight the critical interplay between hematopoietic and bone cells in MDS.
Area of Science:
- Hematology
- Bone Biology
- Pathology
Background:
- Hematopoietic bone marrow and bone cells share a close relationship.
- Hematopoiesis derangements in myelodysplastic syndromes (MDS) may influence bone cell function.
- Understanding this interaction is crucial for managing MDS complications.
Purpose of the Study:
- To investigate the dynamic histomorphometric changes in bone in MDS patients.
- To analyze the influence of hematological disease on bone remodeling processes.
- To elucidate the relationship between hematopoietic and bone cells in MDS.
Main Methods:
- Studied 22 MDS patients using undecalcified transiliac bone biopsies.
- Performed dynamic histomorphometry with double tetracycline labeling.
- Analyzed bone-regulating hormones and serum markers, comparing them to controls.
Main Results:
- MDS patients exhibited significantly decreased osteoblast surface, wall thickness, osteoclast number, mineral apposition rate, bone formation rate, and activation frequency.
- A significant increase in mineralization lag time was observed in MDS patients.
- Bone volume, eroded surfaces, and osteoid thickness remained unchanged compared to controls.
Conclusions:
- MDS is characterized by adynamic bone with reduced bone formation and osteoclast activity.
- Histomorphometric findings in MDS patients reveal significant interactions between hematopoietic and bone cells.
- These bone changes are a characteristic feature of myelodysplastic syndromes.